Comment on

• Encouraging alternatives to seclusion, restraint, and reliance on PRN drugs in a public psychiatric hospital.

  Donat DC. Donat DC. Psychiatr Serv. 2005 Sep;56(9):1105-8. doi: 10.1176/appi.ps.56.9.1105. Psychiatr Serv. 2005. PMID: 16148325
• The economic cost of using restraint and the value added by restraint reduction or elimination.

  Lebel J, Goldstein R. Lebel J, et al. Psychiatr Serv. 2005 Sep;56(9):1109-14. doi: 10.1176/appi.ps.56.9.1109. Psychiatr Serv. 2005. PMID: 16148326
• Pennsylvania State Hospital system's seclusion and restraint reduction program.

  Smith GM, Davis RH, Bixler EO, Lin HM, Altenor A, Altenor RJ, Hardentstine BD, Kopchick GA. Smith GM, et al. Psychiatr Serv. 2005 Sep;56(9):1115-22. doi: 10.1176/appi.ps.56.9.1115. Psychiatr Serv. 2005. PMID: 16148327
• Patients' reports of traumatic or harmful experiences within the psychiatric setting.

  Frueh BC, Knapp RG, Cusack KJ, Grubaugh AL, Sauvageot JA, Cousins VC, Yim E, Robins CS, Monnier J, Hiers TG. Frueh BC, et al. Psychiatr Serv. 2005 Sep;56(9):1123-33. doi: 10.1176/appi.ps.56.9.1123. Psychiatr Serv. 2005. PMID: 16148328
• Consumers' perceptions of negative experiences and "sanctuary harm" in psychiatric settings.

  Robins CS, Sauvageot JA, Cusack KJ, Suffoletta-Maierle S, Frueh BC. Robins CS, et al. Psychiatr Serv. 2005 Sep;56(9):1134-8. doi: 10.1176/appi.ps.56.9.1134. Psychiatr Serv. 2005. PMID: 16148329